Transforming growth factor beta receptor type I kinase (TGFBR1 (also known as ALK5))

Transforming growth factor beta receptor type I kinase is a membrane-bound serine/threonine protein kinase that acts as a key signal transducer for the transforming growth factor beta superfamily. Upon ligand binding, it forms a heteromeric complex with the type II TGF-beta receptor at the cell surface. This complex initiates intracellular signaling cascades that regulate diverse cellular processes including proliferation, differentiation, apoptosis, immune responses, and extracellular matrix production. Dysregulation or mutation of this receptor is implicated in several diseases such as cancer—where it can act both as a tumor suppressor and promoter—fibrotic disorders like renal fibrosis, and genetic syndromes such as Loeys-Dietz syndrome affecting connective tissues. The target is therapeutically relevant; several small molecule inhibitors have been developed to modulate its activity for treatment of cancer and fibrotic diseases.

Other names

Activin A receptor type II-like kinase 5ALK5Serine/threonine-protein kinase receptor R4TBRITGF-beta receptor type ITGFR-1

Inhibition of serine/threonine kinase activity to block downstream TGF-beta signaling, thereby reducing cell proliferation, migration, epithelial-mesenchymal transition (EMT), and fibrosis; can also enhance immune response in cancer therapy by blocking immunosuppressive effects of TGF-beta signaling.